IP Library Patent Application 13971423
Patent Application
App. No. 13/971,423

Control of Cyanate in Aqueous Urea Solutions by Non-1,2-Ethylene Diamine Like Compounds for the Protection of Protein/Peptide Carbamylation

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/971,423
Abstract

Embodiments of the present invention generally relate to processing of peptides in urea solutions and substantial prevention of carbamylation of the peptide.

Claims (15)

1 - 19 . (canceled)

20 . A method of inhibiting and/or delaying carbamylation of a polypeptide in a urea and/or cyanate containing solution, the method comprising a step of adding a carbamylation-inhibiting compound to the solution,

wherein said carbamylation-inhibiting compound is selected from the group consisting of L-Glycine, L-histidine, Diethanolamine, L-Arginine, L-Threonine, L-Lysine, L-Cysteine, Taurine, Hydralazine, 4-Hydroxy-Proline, a dipeptide and Tri-Glycine.

21 . The method according to claim 20 , wherein the polypeptide is a ribonuclease.

22 . The method according to claim 21 , wherein the ribonuclease is RNase A.

23 . The method according to claim 20 , wherein the carbamylation-inhibiting compound is added to the solution in an amount effective to provide about 100% carbamylation protection of the polypeptide for a period of three weeks.

24 . The method according to claim 20 , wherein the concentration of the carbamylation-inhibiting compound is between 1 mM and 150 mM.

25 . The method according to claim 20 , wherein the carbamylation-inhibiting compound has a buffering capacity of about neutral.

26 . A method of inhibiting and/or delaying carbamylation of a polypeptide in a urea and/or cyanate containing solution, the method comprising a step of adding a carbamylation-inhibiting compound to the solution,

wherein the carbamylation-inhibiting compound is selected from the group consisting of L-Glycine, L-histidine, Diethanolamine, L-Arginine, L-Threonine, L-Lysine, L-Cysteine, Taurine, Hydralazine, 4-Hydroxy-Proline, Glycinamide, a dipeptide and Tri-Glycine

27 . The method according to claim 26 , wherein the carbamylation-inhibiting compound has a buffering capacity of about neutral.

28 . A method of inhibiting and/or delaying carbamylation of a polypeptide in a urea and/or cyanate containing solution, the method comprising a step of adding a carbamylation-inhibiting compound selected from the group consisting of L-Glycine, Diethanolamine, L-Arginine, L-Threonine, L-Lysine, L-Cysteine, Taurine, Hydralazine, Glycinamide, a dipeptide and Tri-Glycine to the solution,

wherein the carbamylation-inhibiting compound is added to the solution in an amount effective to provide about 100% carbamylation protection of the polypeptide for a period of three weeks.

29 . The method according to claim 28 , wherein the concentration of the carbamylation-inhibiting compound is between 1 mM and 150 mM.

30 . The method according to claim 29 , wherein the cyanate in the solution is at a concentration of about 5 mM.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2015
From: NV ORGANON
To: FUJIFILM DIOSYNTH BIOTECHNOLOGIES, U.S.A., INC.
Reel/Frame 035106/0794 →